DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20210015

Patterns of neurological deficits in COVID-19 infections: a literature review

Murad Mohammed Ali Alghanmi, Salman Talal Wahboo, Hussain Hassan Al Rashdi, Adel Abdulrahman Alotaibi, Yaser Saeed Alqahtani, Sultan Sameer Alrabghi, Ahmed Ibrahim Almania, Hadeel khalid Elshahti, Abdullah Mohammed Alluhaidah, Mohammed Ali Alshehri, Yaser Amer Alkasih

Abstract


Neurologic deficits accompanying SARS-CoV-2 infections are associated with high mortality and morbidity. However, the exact prevalence and underlying pathogenesis of each disease are still unknown and under investigated. That is why this review reports the latest neurologic disorders diagnosed in COVID-19 patients and the possible underlying pathogenesis. We searched PubMed, Medline, Web of science, Embase, Google scholar, and Scopus using the following search terms; severe acute respiratory syndrome of coronavirus-2 or SARS-CoV-2 or COVID-19 or coronavirus and brain or nerve or neuro. Only studies that reported any neurologic deficits accompanying the COVID-19 diagnosis were included. COVID-19 patients had a wide range of neurologic deficits affecting different parts of the nervous systems. Cerebrovascular disorders, seizures, and cranial nerve diseases were reported in many cases. Autoimmune neuropathy was also reported in many patients. The incidence of neurologic deficits was considered high in COVID-19 patients and was associated with high morbidity and mortality.


Keywords


COVID-19, Neurological deficits, Mortality

Full Text:

PDF

References


Louapre C, Collongues N, Stankoff B. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020;77(9):1079-88.

Dawood FS, Ricks P, Njie GJ. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. Lancet Infect Dis. 2020;20 (11):1255-62.

Mao L, Jin H, Wang M. Neurologic Manifestations of Hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6): 683-90.

Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SMS. First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol. 2020;92(10):2238-42.

Shadi Y, Koto I, Jose T. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7): 2002-11.

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018-27.

Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J KoreanMed Sci. 2020;35(18):e174.

Hanafi R, Roger PA, Perin B. COVID-19 neurologic complication with cns vasculitis-like pattern. Am J Neuroradiol. 2020;41(8):1384-7.

Kaya Y, Kara S, Akinci C, Kocaman AS. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report. J Neurol Sci. 2020;413: 116858.

Kishfy L, Casasola M, Banankhah P. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. J Neurol Sci. 2020;414:116943.

Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM) like pathology. Acta Neuropathol. 2020; 140(1):1-6.

Fara MG, Stein LK, Skliut M, Morgello S, Fifi JT, Dhamoon MS. Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost. 2020;18(8):2031-3.

Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis/ encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020;415:116941.

Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electro-physiol. 2020;31(5):1003-8.

Lodigiani C, Iapichino G, Carenzo L. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14.

Chougar L, Mathon B, Weiss N, Degos V, Shor N. Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. Am J Neuroradiol. 2020;41(8):1377-9.

Degeneffe A, Bruneau M, Spitaels J, Gilis N, De Witte O, Lubansu A. Acute hemorrhage after intracerebral biopsy in COVID-19 patients: report of 3 cases. World Neurosurg. 2020;141:157-61.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19, associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiol. 2020;296(2):E119-20.

Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A. Generalized myoclonus in COVID-19. Neurol. 2020;95(6):e767-72.

Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure. 2020;79:49-52.

Demirci Otluoglu G, Yener U, Demir MK, Yilmaz B. Encephalomyelitis associated with Covid-19 infection: case report. Br J Neurosurg. 2020:1-3.

Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, Lewis A. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020;61(10): e135-9.

Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E. Neurologic manifestations in hospitalized patients with COVID-19. Neurol. 2020;95(8):e1060-70.

Virhammar J, Kumlien E, Fällmar D. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurol. 2020;95 (10):445-9.

Serdaroğlu E, Serdaroğlu A. COVID-19 and neurological manifestations. Turkiye Klinikleri J Med Sci. 2020;40(2):269-71.

Morsy S. NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Med Hypotheses. 2020;145:110342.

Toscano G, Palmerini F, Ravaglia S. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6.

Varatharaj A, Thomas N, Ellul MA. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875-82.

Oxley TJ, Mocco J, Majidi S. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60.

Ranucci M, Ballotta A, Di Dedda U. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18(7):1747-51.

Speeckaert MM, Speeckaert R, Delanghe JR. Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19. J Neuroradiol. 2020;47(6):473-4.

Radmanesh A, Derman A, Ishida K. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy. J Neurol Sci. 2020;415:1-3.

Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e803.

Princiotta Cariddi L, Tabaee Damavandi P, Carimati F. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. J Neurol. 2020;267(11):3157-60.

Vollono C, Rollo E, Romozzi M, et al. Focal status epilepticus as unique clinical feature of COVID-19: A case report. Seizure. 2020;78:109-12.

Galanopoulou AS, Ferastraoaru V, Correa DJ. EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report. Epilepsia Open. 2020;5(2):314-24.

Pilato MS, Urban A, Alkawadri R, et al. EEG Findings in Coronavirus Disease. J Clin Neuro-physiol. 2020.

Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020;77(8):1028-9.

Selvaraj V, Sacchetti D, Finn A, Dapaah-Afriyie K. Acute vision loss in a patient with COVID-19. MedRxiv. 2020.

Ferreira ACAdF, Romão TT, Macedo YS, Pupe C, Nascimento OJM, Neurology FotAAo. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. EurJ Neurol. 2020;27(9): 1748-50.

Zoghi A, Ramezani M, Roozbeh M, Darazam IA, Sahraian MA. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult Scler Relat Disord. 2020; 44:102324.

Abdi S, Ghorbani A, Fatehi F. The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms. J Neurol Sci. 2020;416: 117001.

Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis. J Neurol. 2020;267 (10):2799-802.

Berger JR, Brandstadter R, Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e761.

AlKetbi R, AlNuaimi D, AlMulla M. Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings. Radiol Case Rep. 2020; 15(9):1591-5.

Munz M, Wessendorf S, Koretsis G. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020;267(8):2196-7.

Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurol. 2020;95 (15):e2109-18.

Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord. 1992;7(2):153-8.

Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental?. New Microbes New Infect. 2020;35:100669.